A 68-year-old man was diagnosed with a SMARCA4-deficient thoracic sarcomatoid tumor. Immunochemotherapy with carboplatin, paclitaxel, and pembrolizumab followed by maintenance therapy with pembrolizumab resulted in clinically meaningful remission.
Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report
Verfasst von
Clemens Petrasch, MD
Simon Udovica, MD
Frédéric Witte, MD
Bernadette Liegl-Atzwanger, MD
Wolfgang Pokieser, MD
Siroos Mirzaei, MD
Wolfgang Hilbe, MD
Andrea Kaufmann-Keck, MD
